Patents by Inventor Kamlendra Singh

Kamlendra Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE INHIBITORS FOR THE INHIBITION OF HIV CAPSID
    Publication number: 20220306690
    Abstract: Provide for herein are cyclic or linear peptides that bind HIV-1 capsid protein and inhibit HIV-1 capsid from assembling and/or disassembling. Further provided are methods of making said peptides and pharmaceutical compositions and methods for treating HIV infection.
    Type: Application
    Filed: June 8, 2020
    Publication date: September 29, 2022
    Inventors: Ujjwal Neogi, Anders Sonnerborg, Kamlendra Singh, Thomas P. Quinn, Fabio Gallazzi
  • Aryl and heteroaryl amides for use as anti-proliferative, anti-thrombotic, and anti-viral agents
    Patent number: 10851096
    Abstract: Certain compounds of formula I: I and salts including pharmaceutically acceptable salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods using a compound of formula I.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: December 1, 2020
    Assignees: Rutgers, The State University of New Jersey, The Curators of the University of Missouri
    Inventors: William J. Welsh, Raymond Birge, Vladyslav Kholodovych, Youyi Peng, Thomas Walter Comollo, Stanley G. Kimani, Kamlendra Singh
  • Therapeutic Compounds
    Publication number: 20190127361
    Abstract: Certain compounds of formula I: I and salts including pharmaceutically acceptable salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I, intermediates useful for preparing compounds of formula I and therapeutic methods using a compound of formula I.
    Type: Application
    Filed: June 16, 2017
    Publication date: May 2, 2019
    Applicants: Rutgers, The State University of New Jersey, The Curators of the University of Missouri
    Inventors: William J. Welsh, Raymond Birge, Vladyslav Kholodovych, Youyi Peng, Thomas Walter Comollo, Stanley G. Kimani, Kamlendra Singh
  • Suppression of SARS replication by SARS helicase inhibitors
    Patent number: 9266844
    Abstract: The present invention relates to compounds, compositions, and methods, for treating subjects suspected of needing treatment for a Nidovirales virus infection. In certain embodiments, the compounds comprise Nidovirales helicase inhibitors that do not significantly affect helicase ATPase enzymatic activity or nucleic acid binding activity of the helicase.
    Type: Grant
    Filed: June 17, 2013
    Date of Patent: February 23, 2016
    Assignee: The Curators of the University of Missouri
    Inventors: Stefan G. Sarafianos, Adeyemi O. Adedeji, Kamlendra Singh
  • Suppression of Sars Replication by Sars Helicase Inhibitors
    Publication number: 20140005241
    Abstract: The present invention relates to compounds, compositions, and methods, for treating subjects suspected of needing treatment for a Nidovirales virus infection. In certain embodiments, the compounds comprise Nidovirales helicase inhibitors that do not significantly affect helicase ATPase enzymatic activity or nucleic acid binding activity of the helicase.
    Type: Application
    Filed: June 17, 2013
    Publication date: January 2, 2014
    Applicant: The Curators of the University of Missouri
    Inventors: Stefan G. Sarafianos, Adeyemi O. Adedeji, Kamlendra Singh